About atkinson biologics consulting

Brent L. Atkinson, Ph.D. has more than 25 years of proven leadership experience in the development of Biologics for orthopedic, spine, sports medicine and dental products and has been consulting since 2012. 

Prior to starting the consulting company, his successful track record included worldwide commercialization of PepGen P-15 dental bone graft, Amplex/ PreFix for spine and foot/ ankle arthrodesis that was sold to a pharmaceutical company and commercialization of several human tissues (Section 361 HCT/Ps).

He has led preclinical and clinical studies,  regulatory fillings, and manufacturing for several programs.

Brent currently has 30+ presentations and publications and 11+ issued patents.

Brent holds a Doctorate in Molecular Biology from Columbia University in New York City and a Bachelor of Science degree in Genetics from the University of California, Davis.

Effective product development and commercialization requires expertise for  the specific medical field and for preclinical, regulatory, manufacturing and clinical areas. This holistic approach results in a time and cost- effective investment to grow your business.

Clinical support for your program is provided by an expert in the medical field who provides comprehensive support from clinical design strategy and IRB approval through study execution, data analysis and manuscript writing. This approach results in a reduced cost and  increased quality compared to CROs.